AI assistant
Sending…
ABBOTT LABORATORIES — Director's Dealing 2015
Apr 2, 2015
29777_dirs_2015-04-02_7f241469-d89a-4efd-86f0-d1b5a203d659.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2015-04-01
Reporting Person: NATH DEEPAK S. (Senior Vice President)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 35757 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option (right to buy) | $38.10 | 2024-04-27 | Common shares (15553) | Direct | |
| Option (right to buy) | $38.10 | 2024-04-27 | Common shares (15552) | Direct | |
| Option (right to buy) | $38.10 | 2024-04-27 | Common shares (15553) | Direct | |
| Option (right to buy) | $47 | 2025-02-19 | Common shares (38231) | Direct | |
| Option (right to buy) | $47 | 2025-02-19 | Common shares (38230) | Direct | |
| Option (right to buy) | $47 | 2025-02-19 | Common shares (38231) | Direct |
Footnotes
F1: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
More from ABBOTT LABORATORIES
Regulatory Filings
2026
Jul 16
Annual Report
2026
Jun 18
Regulatory Filings
2026
May 27
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Board/Management Information
2026
Apr 27
Regulatory Filings
2026
Apr 24
Legal Proceedings Report
2026
Apr 17
Call Transcript
2026
Apr 16
Earnings Release
2026
Apr 16